330
Participants
Start Date
October 1, 2020
Primary Completion Date
March 7, 2025
Study Completion Date
March 7, 2025
Heparin
Administration of heparin with a target of 2-2.5 or 1.5-2.0 times baseline aPTT during ECLS.
LMWH
Administration of LMWH guided by weight and renal function during ECLS.
Radboud UMC, Nijmegen
Maastricht Universitair Medisch Centrum+, Maastricht
OLVG, location East, Amsterdam
Amsterdam UMC, location AMC, Amsterdam
Isala Clinics, Zwolle
University Medical Center Groningen, Groningen
Leids Universitair Medisch Centrum, Leiden
Erasmus MC, Rotterdam
Collaborators (1)
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Erasmus Medical Center
OTHER
Leiden University Medical Center
OTHER
St. Antonius Hospital
OTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Isala
OTHER
OLVG
NETWORK
Radboud University Medical Center
OTHER
University Medical Center Groningen
OTHER